戊酸倍他米松

戊酸倍他米松（CAS 2152-44-5）的公开数据库记录，列此仅供独立核对。

危险化学品分类与危害说明

物理形态与操作说明

• 215.5 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID7022673]
• 214 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

这个物质在各数据库里的编号

数据库记载的用途

• Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients
• Substances that reduce or suppress INFLAMMATION.
• A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.
• Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
• Corticosteroid [EPC]; Corticosteroid Hormone Receptor Agonists [MoA]

它在各数据库里的别名

BETAMETHASONE VALERATE; Betamethasone 17-valerate; 2152-44-5; Valisone; beta-Val; Betaderm; Tokuderm; Luxiq; Betatrex; Dermabet; Valnac; Rinderon V; Bextasol; Stanoval; DTXSID7022673; Bettamousse

计算机算出的分子描述符

数据库摘要

Betamethasone Valerate · CAS 2152-44-5 · C27H37FO6. UNII 9IFA5XM7R2.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。